Remus Pharmaceuticals Limited IPO is set to launch on 17 May, 2023. The company initiated its business operations in the year 2005. Its business as the name suggests is related to the pharmaceutical sector. It is involved in distributing and marketing finished formulations for pharma drugs. It has 2 product categories namely APIs and Finished formulations of pharmaceuticals. The product portfolio includes more than 425 products. It has 295 products registered in 13 countries and 134 products registered in 16 countries. It has a network of 59 domestic and 139 international distributors.
Remus Pharmaceuticals Limited IPO DETAILS
Remus Pharmaceuticals Limited IPO is set to launch on 17 May., 2023. The subscription timeline extends till 19 May, 2023. The size for the IPO is 47.69 Crore Rs. Shares issued through fresh issue mode are worth 47.69 Crore Rs. No Shares are issued through offer for sale mode. The lot size is 100 shares and the price is 1150 to 1229 Rs per share. The company is going to get listed at NSE SME. The face value per share is Rs.10 and this is a Book Built issue. The registrar for the company is Link Intime India Private Limited.
Tabular Description of Remus Pharmaceuticals Limited IPO
IPO OPENING DATE | 17 May., 2023 |
CLOSING DATE FOR IPO | 19 May, 2023 |
ISSUE TYPE | Book Built Issue |
Face Value per share | 10 Rs. per share |
IPO price band | 1150 to 1229 Rs per share |
LOT SIZE | 100 shares |
MINIMUM ORDER QUANTITY | 100 shares |
ISSUE SIZE | 47.69 Crore Rs. |
OFFER FOR SALE | No shares are issued through offer for sale mode. |
FRESH ISSUE | 47.69 Crore Rs. |
LISTING AT | NSE SME |
LISTING DATE | 29 May, 2023 |
Remus Pharmaceuticals Limited IPO : IMPORTANT DATES
IPO OPENING DATE | 17 May., 2023 |
CLOSING DATE FOR IPO | 19 May., 2023 |
IPO ALLOTMENT DATE | 24 May., 2023 |
REFUNDS | 25 May., 2023 |
DEMAT A/C CREDITED ON | 26 May., 2023 |
IPO LISTING DATE | 29 May., 2023 |
Remus Pharmaceuticals Limited IPO begins for subscription from 17 May., 2023. The IPO subscription would continue till 19 May., 2023. The allotment status for the shareholders who applied would come on 24 May., 2023. The refunds for the ones who did not get allotment would be initiated on 25 May., 2023. The DEMAT accounts of shareholders would be credited on 26 May., 2023. The listing of the company would be accompanied on 29 May., 2023.
Remus Pharmaceuticals Limited IPO : Lead Managers
The lead managers are :
- Beeline Capital Advisors Private Limited
The minimum lot size for the company is decided at 100 shares. This holding accounts to 122900 Rs.. The maximum lot size is decided at 200 shares (HNI). This amounts to 245800 Rs.. Hence the company’s final holdings would be set as :
Shares | Amount | |
Minimum | 100 shares | 122900 Rs. |
Maximum | 200 shares | 245800 Rs. |
OBJECTIVES FOR THE IPO
- IPO proceeds would be used for general corporate purposes.
- The Issue proceeds will be utilised for fulfilling the working capital requirements.
COMPANY FINANCIALS
Particularly (in Lakh Rs.) | 2019-20 | 2020-21 | 2021-22 |
ASSETS | 530 | 1104 | 1590 |
Revenue | 1276 | 1922 | 2543 |
PAT | 81 | 102 | 338 |
Remus Pharmaceuticals Limited had an asset base of more than 530 Lklah Rs in 2020. This increased to 1105 Lakh Rs in 2021. This means the assets of the company doubled within a year. Also in 2022 the assets increased to a total of 1590 Lakh Rs. The revenue of the firm has been 1276 Lakh Rs in 2020. This went on to 1922 Lkah Rs in 2021 and 2543 Lakh Rs in 2022. Thus in 2 years the revenue of the firm also doubled. The company has been profitable in the last 3 years as well. The profit of the firm was 81 Lakh Rs in 2020. This went on to 102 Lkah Rs in 2021 and 338 Lakh Rs in 2022.
PROS
- It has 2 product categories namely APIs and Finished formulations of pharmaceuticals.
- The product portfolio includes more than 425 products.
- It has 295 products registered in 13 countries and 134 products registered in 16 countries.
- The company has a network of 59 domestic and 139 international distributors.
CONS
- The company works into a very competitive segment.
Remus Pharmaceuticals Limited IPO APPLICATION PROCESS WITH ZERODHA
It is very easy to apply for an IPO now if you have a DEMAT account with Zerodha. Follow the steps below for the same :
- Logging into Zerodha console through its website or KITE platform.
- Clicking the IPO link present in the Portfolio section.
- Click the Remus Pharmaceuticals Limited IPO button and press the BID button.
- Entering the details asked for like UPI ID, Quantity and price.
- Submit the application form for the IPO.
- Visiting the application of UPI for approving the transaction.
Now, applying for an IPO online is possible with most of the Discount and online brokers.